Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. META
5. SPY
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients
(NASDAQ: TLSA) Delayed: 1.16 +0.01 (0.87%)
Previous Close $1.15    52 Week High $ 
Open $1.13    52 Week Low $ 
Day High $1.17    P/E N/A 
Day Low $1.11    EPS $ 
Volume 59,549